Clinical Trial Update: Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and efficacy assessment of Mix Vaccine in hepatocellular carcinoma. The Phase 1/Phase 2 study sponsored by Fuda Cancer Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Mix Vaccine

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Liver Neoplasms | Phase 1, Phase 2 | Status: COMPLETED